HEADER HYDROLASE 03-NOV-09 3KJF TITLE CASPASE 3 BOUND TO A COVALENT INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASPASE-3; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CASP-3, APOPAIN, CYSTEINE PROTEASE CPP32, CPP-32, YAMA COMPND 5 PROTEIN, SREBP CLEAVAGE ACTIVITY 1, SCA-1, CASPASE-3 SUBUNIT P17, COMPND 6 CASPASE-3 SUBUNIT P12; COMPND 7 EC: 3.4.22.56; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: CASPASE-3; COMPND 11 CHAIN: B; COMPND 12 SYNONYM: CASP-3, APOPAIN, CYSTEINE PROTEASE CPP32, CPP-32, YAMA COMPND 13 PROTEIN, SREBP CLEAVAGE ACTIVITY 1, SCA-1, CASPASE-3 SUBUNIT P17, COMPND 14 CASPASE-3 SUBUNIT P12; COMPND 15 EC: 3.4.22.56; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CASP3, CPP32; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: CASP3, CPP32; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS CASPASE 3, APOPTOSIS, KINETICS, PEPTIDOMIMETIC INHIBITOR, URAZOLE, KEYWDS 2 PHOSPHOPROTEIN, PROTEASE, S-NITROSYLATION, THIOL PROTEASE, ZYMOGEN, KEYWDS 3 HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR S.KAMTEKAR,W.WATT,B.C.FINZEL,M.S.HARRIS,J.BLINN,Z.WANG,A.G.TOMASSELLI REVDAT 1 11-AUG-10 3KJF 0 JRNL AUTH Z.WANG,W.WATT,N.A.BROOKS,M.S.HARRIS,J.URBAN,D.BOATMAN, JRNL AUTH 2 M.MCMILLAN,M.KAHN,R.L.HEINRIKSON,B.C.FINZEL,A.J.WITTWER, JRNL AUTH 3 J.BLINN,S.KAMTEKAR,A.G.TOMASSELLI JRNL TITL KINETIC AND STRUCTURAL CHARACTERIZATION OF CASPASE-3 AND JRNL TITL 2 CASPASE-8 INHIBITION BY A NOVEL CLASS OF IRREVERSIBLE JRNL TITL 3 INHIBITORS. JRNL REF BIOCHIM.BIOPHYS.ACTA V.1804 1817 2010 JRNL REFN ISSN 0006-3002 JRNL PMID 20580860 JRNL DOI 10.1016/J.BBAPAP.2010.05.007 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0102 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 18.71 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 89.2 REMARK 3 NUMBER OF REFLECTIONS : 16700 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.183 REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.206 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.800 REMARK 3 FREE R VALUE TEST SET COUNT : 1822 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 822 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 60.24 REMARK 3 BIN R VALUE (WORKING SET) : 0.2380 REMARK 3 BIN FREE R VALUE SET COUNT : 78 REMARK 3 BIN FREE R VALUE : 0.2370 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1940 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 43 REMARK 3 SOLVENT ATOMS : 152 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 15.37 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.75000 REMARK 3 B22 (A**2) : -0.85000 REMARK 3 B33 (A**2) : 3.60000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.199 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.159 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.094 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.260 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.956 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.947 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2035 ; 0.009 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1390 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2739 ; 1.347 ; 1.975 REMARK 3 BOND ANGLES OTHERS (DEGREES): 3363 ; 0.841 ; 3.001 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 242 ; 6.037 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 97 ;33.981 ;23.505 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 361 ;13.216 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 15 ;16.573 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 292 ; 0.080 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2268 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 432 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1203 ; 0.426 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 492 ; 0.094 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1939 ; 0.799 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 832 ; 1.351 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 799 ; 2.117 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : X 34 X 278 REMARK 3 ORIGIN FOR THE GROUP (A): 10.1825 6.8699 2.3314 REMARK 3 T TENSOR REMARK 3 T11: 0.0229 T22: 0.0293 REMARK 3 T33: 0.0257 T12: -0.0108 REMARK 3 T13: 0.0043 T23: -0.0235 REMARK 3 L TENSOR REMARK 3 L11: 2.5730 L22: 2.1403 REMARK 3 L33: 1.2235 L12: -0.3809 REMARK 3 L13: 0.2099 L23: -0.2385 REMARK 3 S TENSOR REMARK 3 S11: -0.1033 S12: -0.1067 S13: 0.1867 REMARK 3 S21: 0.1050 S22: 0.0891 S23: -0.0378 REMARK 3 S31: -0.0698 S32: 0.0372 S33: 0.0142 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3KJF COMPLIES WITH FORMAT V. 3.20, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-NOV-09. REMARK 100 THE RCSB ID CODE IS RCSB056066. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : SI(111) DOUBLE-CRYSTAL REMARK 200 MONOCHROMATOR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16700 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 89.2 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.05 REMARK 200 COMPLETENESS FOR SHELL (%) : 60.2 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: INHIBITOR (2 MICROLITERS OF A 100 MM REMARK 280 DMSO STOCK) ADDED TO 100 MICROLITERS OF PROTEIN (6.5 MG/ML) IN 20 REMARK 280 MM TRIS, 10 MM DTT PH 8.0. DROPS CONTAINED EQUAL VOLUMES OF REMARK 280 PROTEIN AND WELL SOLUTION (16% ETHANOL, 0.1 M TRIS PH 7.8), VAPOR REMARK 280 DIFFUSION, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 48.34500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.08000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 48.34500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 34.08000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 14500 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18410 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -77.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 29 REMARK 465 GLY A 30 REMARK 465 ILE A 31 REMARK 465 SER A 32 REMARK 465 LEU A 33 REMARK 465 THR A 174 REMARK 465 ASP A 175 REMARK 465 HIS B 278 REMARK 465 HIS B 279 REMARK 465 HIS B 280 REMARK 465 HIS B 281 REMARK 465 HIS B 282 REMARK 465 HIS B 283 REMARK 465 HIS B 284 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 HIS A 56 CG ND1 CD2 CE1 NE2 REMARK 470 LYS A 57 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 144 151.52 -47.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE B92 B 285 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3KJN RELATED DB: PDB REMARK 900 CASPASE 8 BOUND TO A COVALENT INHIBITOR REMARK 900 RELATED ID: 3KJQ RELATED DB: PDB REMARK 900 CASPASE 8 WITH COVALENT INHIBITOR REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE RESIDUE AT POSITION 190 CHAIN B, IS A NATURAL VARIANT, AS REMARK 999 LISTED IN UNP ENTRY P42574 DBREF 3KJF A 29 175 UNP P42574 CASP3_HUMAN 29 175 DBREF 3KJF B 176 277 UNP P42574 CASP3_HUMAN 176 277 SEQADV 3KJF ASP B 190 UNP P42574 GLU 190 SEE REMARK 999 SEQADV 3KJF HIS B 278 UNP P42574 EXPRESSION TAG SEQADV 3KJF HIS B 279 UNP P42574 EXPRESSION TAG SEQADV 3KJF HIS B 280 UNP P42574 EXPRESSION TAG SEQADV 3KJF HIS B 281 UNP P42574 EXPRESSION TAG SEQADV 3KJF HIS B 282 UNP P42574 EXPRESSION TAG SEQADV 3KJF HIS B 283 UNP P42574 EXPRESSION TAG SEQADV 3KJF HIS B 284 UNP P42574 EXPRESSION TAG SEQRES 1 A 147 SER GLY ILE SER LEU ASP ASN SER TYR LYS MET ASP TYR SEQRES 2 A 147 PRO GLU MET GLY LEU CYS ILE ILE ILE ASN ASN LYS ASN SEQRES 3 A 147 PHE HIS LYS SER THR GLY MET THR SER ARG SER GLY THR SEQRES 4 A 147 ASP VAL ASP ALA ALA ASN LEU ARG GLU THR PHE ARG ASN SEQRES 5 A 147 LEU LYS TYR GLU VAL ARG ASN LYS ASN ASP LEU THR ARG SEQRES 6 A 147 GLU GLU ILE VAL GLU LEU MET ARG ASP VAL SER LYS GLU SEQRES 7 A 147 ASP HIS SER LYS ARG SER SER PHE VAL CYS VAL LEU LEU SEQRES 8 A 147 SER HIS GLY GLU GLU GLY ILE ILE PHE GLY THR ASN GLY SEQRES 9 A 147 PRO VAL ASP LEU LYS LYS ILE THR ASN PHE PHE ARG GLY SEQRES 10 A 147 ASP ARG CYS ARG SER LEU THR GLY LYS PRO LYS LEU PHE SEQRES 11 A 147 ILE ILE GLN ALA CYS ARG GLY THR GLU LEU ASP CYS GLY SEQRES 12 A 147 ILE GLU THR ASP SEQRES 1 B 109 SER GLY VAL ASP ASP ASP MET ALA CYS HIS LYS ILE PRO SEQRES 2 B 109 VAL ASP ALA ASP PHE LEU TYR ALA TYR SER THR ALA PRO SEQRES 3 B 109 GLY TYR TYR SER TRP ARG ASN SER LYS ASP GLY SER TRP SEQRES 4 B 109 PHE ILE GLN SER LEU CYS ALA MET LEU LYS GLN TYR ALA SEQRES 5 B 109 ASP LYS LEU GLU PHE MET HIS ILE LEU THR ARG VAL ASN SEQRES 6 B 109 ARG LYS VAL ALA THR GLU PHE GLU SER PHE SER PHE ASP SEQRES 7 B 109 ALA THR PHE HIS ALA LYS LYS GLN ILE PRO CYS ILE VAL SEQRES 8 B 109 SER MET LEU THR LYS GLU LEU TYR PHE TYR HIS HIS HIS SEQRES 9 B 109 HIS HIS HIS HIS HIS HET B92 B 285 43 HETNAM B92 (3S)-3-({[(5S,10AS)-2-{(2S)-4-CARBOXY-2- HETNAM 2 B92 [(PHENYLACETYL)AMINO]BUTYL}-1,3-DIOXO-2,3,5,7,8,9,10, HETNAM 3 B92 10A-OCTAHYDRO-1H-[1,2,4]TRIAZOLO[1,2-A]CINNOLIN-5- HETNAM 4 B92 YL]CARBONYL}AMINO)-4-OXOPENTANOIC ACID FORMUL 3 B92 C29 H35 N5 O9 FORMUL 4 HOH *152(H2 O) HELIX 1 1 HIS A 56 GLY A 60 5 5 HELIX 2 2 GLY A 66 LEU A 81 1 16 HELIX 3 3 THR A 92 LYS A 105 1 14 HELIX 4 4 LEU A 136 PHE A 142 1 7 HELIX 5 5 CYS A 148 THR A 152 5 5 HELIX 6 6 TRP B 214 ALA B 227 1 14 HELIX 7 7 GLU B 231 PHE B 247 1 17 HELIX 8 8 ASP B 253 HIS B 257 5 5 SHEET 1 A 6 GLU A 84 ASN A 89 0 SHEET 2 A 6 GLU A 43 ASN A 51 1 N ASN A 51 O LYS A 88 SHEET 3 A 6 ARG A 111 LEU A 119 1 O VAL A 117 N ILE A 48 SHEET 4 A 6 LYS A 156 GLN A 161 1 O LEU A 157 N PHE A 114 SHEET 5 A 6 PHE B 193 TYR B 197 1 O LEU B 194 N PHE A 158 SHEET 6 A 6 CYS B 264 SER B 267 -1 O VAL B 266 N TYR B 195 SHEET 1 B 3 GLY A 122 GLU A 123 0 SHEET 2 B 3 ILE A 126 GLY A 129 -1 O ILE A 126 N GLU A 123 SHEET 3 B 3 GLY A 132 ASP A 135 -1 O GLY A 132 N GLY A 129 SHEET 1 C 2 ARG B 207 ASN B 208 0 SHEET 2 C 2 GLY B 212 SER B 213 -1 O GLY B 212 N ASN B 208 LINK SG CYS A 163 C1 B92 B 285 1555 1555 1.80 SITE 1 AC1 15 ARG A 64 HIS A 121 GLY A 122 GLN A 161 SITE 2 AC1 15 CYS A 163 ASP B 179 TYR B 204 SER B 205 SITE 3 AC1 15 TRP B 206 ARG B 207 ASN B 208 SER B 209 SITE 4 AC1 15 TRP B 214 PHE B 250 HOH B 325 CRYST1 96.690 68.160 44.770 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010342 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014671 0.000000 0.00000 SCALE3 0.000000 0.000000 0.022336 0.00000